ORN Partner Organization Sponsor: National Alliance for HIV Education and Workforce Development
This session is part of a national webinar series called Bridging HIV and SUD: Innovations in the Field. The series is highlighting various innovative models and approaches to treating substance use disorder in people at risk for and living with HIV. This presentation will describe the impact and management of a new adulterant in the opioid drug supply.
This presentation will explore impacts and management of a new adulterant in the opioid drug supply.
Learning objectives:
- Understand medetomidine as an alpha-2-agonist.
- Describe medetomidine withdrawal.
- Learn management techniques for alpha-2-agonist withdrawal.